Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants

BMC Pediatrics

Volumn 5, Issue , 2005, Pages

  Lin, Nancy D ^a   Kleinman, Ken ^a,a   Chan, K Arnold ^b   Yu, Xian Jie ^a   France, Eric K ^c   Xu, Stanley ^c   Wei, Feifei ^d   Mullooly, John ^e   Santoli, Jeanne ^f   Lieu, Tracy A ^a   DeStefano, Frank ^g   Chen, Robert T ^g   Shay, David ^g   Rhodes, Philip H ^g   Kolzcak, Margarette ^g   Gee, Philip H ^g   Davis, Robert L ^g   Thompson, William ^g   Baggs, James ^g   Barry, Brooke ^g   Bridges, Carolyn ^g   Campbell, Scott ^g   Casey, Chris ^g   Chen, Jufu ^g   Denson, Charissa ^g   Elswich, David ^g   Euler, Gary ^g   Gargiullo, Paul ^g   Harpaz, Rafael ^g   Hibbs, Beth ^g   Jumaan, Aisha ^g   King, David ^g   Kohl, Katrin S ^g   Kramarz, Piotr ^g   Mootrey, Gina ^g   Moran, John ^g   Nuorti, Pekka ^g   Pool, Vitali ^g   Singleton, James ^g   Weintraub, Eric ^g   Weniger, Bruce ^g   Wharton, Melinda ^g   Xu, Fujie ^g   Zhou, Weigong ^g   Braun, M Miles ^h   Wise, Robert P ^h   Ball, Robert ^h   Burwen, Dale ^h   Davis, David ^h   Izurieta, Hector ^h   McMahon, Ann W ^h   Varricchio, Fred ^h   Woo, Jane ^h   Jackson, Lisa ⁱ   Benson, Patti ⁱ   Bohlke, Kari ⁱ   Carste, Barbara ⁱ   Dunn, John ⁱ   Hanson, Christi ⁱ   Jackson, Mike ⁱ   Malais, Darren ⁱ   Nelson, Jennifer ⁱ   Neuzil, Kathleen ⁱ   Scott, Troy J ⁱ   Vora, Neil ⁱ   Yu, Onchee ⁱ   Zavitkovsky, Ann ⁱ   Lieu, Tracy ^a   Platt, Richard ^a   Cain, Emily ^a   Dhall, Jyotsna ^a   Finkelstein, Jonathan ^a   Fox, Richard ^a   Gay, Charlene ^a   Hohman, Katherine ^a   Kulldorf, Martin ^a   Lee, Grace ^a   Lin, Nancy ^a   O'Brien, Megan ^a   Prosser, Lisa ^a   Rego, Virginia ^a   Yih, Katherine ^a   Goodman, Mike ^d   Nordin, Jim ^d   Adlis, Susan ^d   Amundson, Jerry ^d   Anderson, Renner ^d   Butani, Amy ^d   Fillbrandt, Kelly ^d   Godlevsky, Olga ^d   Harper, Peter ^d   Kuckler, Leslie ^d   McBean, A Marshall ^d   McCarty, Maribet ^d   Molitor, Beth ^d   Nelson, Andrew ^d   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KAISER PERMANENTE   (United States)

^d HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f CENTERS FOR DIS CONTR AND PREV   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

ⁱ CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; HAEMOPHILUS VACCINE;

ARTICLE; CHILD; COHORT ANALYSIS; COMPUTER ANALYSIS; DATA ANALYSIS; HEALTH CARE ACCESS; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; STATISTICAL MODEL; VACCINATION; CONTROLLED STUDY; IMMUNIZATION; OUTCOME ASSESSMENT; REPEATED DRUG DOSE; CLINICAL TRIAL; HEALTH MAINTENANCE ORGANIZATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PNEUMOCOCCAL INFECTION; UTILIZATION REVIEW;

COHORT STUDIES; HAEMOPHILUS VACCINES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; VACCINATION;

EID: 28844493944     PISSN: 14712431     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-5-43     Document Type: Article

References (24)

1. Recommended childhood immunization schedule - United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51(2):31-33.
2. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC: General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 2002, 51(RR-2):1-35.
3. Zimmerman RK, Schlesselman JJ, Baird AL, Mieczkowski TA: A national survey to understand why physicians defer childhood immunizations. Arch Pediatr Adolesc Med 1997, 151(7):657-664.
4. Schaffer SJ, Szilagyi PG, Shone LP, Ambrose SJ, Dunn MK, Barth RD, Edwards K, Weinberg GA, Balter S, Schwartz B: Physician perspectives regarding pneumococcal conjugate vaccine. Pediatrics 2002, 110(6):e68.
5. Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG: Physician and parent opinions. Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med 1995, 149(8):845-849.
6. Lee KC, Finkelstein JA, Miroshnik IL, Rusinak D, Santoli JM, Lett SM, Lieu TA: Pediatricians' self-reported clinical practices and adherence to national immunization guidelines after the introduction of pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med 2004, 158(7):695-701.
7. Davis MM, Ndiaye SM, Freed GL, Clark SJ: One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract 2003, 16(5):363-371.
8. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP,Wassilak SG, Hadler SC: Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997, 99(6):765-773.
9. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000,49(RR-9):1-35.
10. Rodewald L, Maes E, Stevenson J, Lyons B, Stokley S, Szilagyi P: Immunization performance measurement in a changing immunization environment. Pediatrics 1999, 103(4 Pt 2):889-897.
11. Davis RL, Lieu TA, Mell LK, Capra AM, Zavitkovsky A, Quesenberry CP, Jr., Black SB, Shinefield HR, Thompson RS, Rodewald LE: Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations. Pediatrics 2001, 107(4):671-676.
12. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999, 48(26):563-565.
13. Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR Morb Mortal Wkly Rep 1999, 48(35):780-782.
14. Oram RJ, Daum RS, Seal JB, Lauderdale DS: Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. Jama 2001,285(14):1874-1879.
15. Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL: Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med 2001, 155(8):915-920.
16. Hurie MB, Saari TN, Davis JP: Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Pediatrics 2001, 107(4):755-758.
17. Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G: Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan. Pediatrics 2003, 111(6 Pt 1):e645-649.
18. Lachenbruch PA: Analysis of data with excess zeros. Stat Methods Med Res 2002, 11(4):297-302.
19. Agresti A: Categorical data analysis. New York: Wiley; 1990.
20. Kolasa MS, Petersen TJ, Brink EW, Bulim ID, Stevenson JM, Rodewald LE: Impact of multiple injections on immunization rates among vulnerable children. Am J Prev Med 2001, 21(4):261-266.
21. Davis MM, Andreae M, Freed GL: Physicians' early challenges related to the pneumococcal conjugate vaccine. Ambul Pediatr 2001, 1(6):302-305.
22. Meyerhoff A, Jacobs RJ, Greenberg DP, Yagoda B, Castles CG: Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE Study (Combination Vaccines Impact on Satisfaction and Epidemiology). Clin Pediatr (Phila) 2004, 43(1):87-93.
23. National, state, and urban area vaccination coverage among children aged 19-35 months - United States, 2003. MMWR Morb Mortal Wkly Rep 2004, 53(29):658-661.
24. Davis RL, Coplan P, Mell L, Black S, Shinefield H, Lewis E: Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rates in a large West Coast health maintenance organization. Pediatr Infect Dis J 2003, 22(7):657-658.